Breast Implants Market Size, Share & COVID-19 Impact Analysis, By Product (Breast Implants and Tissue Expanders), By Material (Silicone and Saline), By Procedure (Breast Augmentation and Breast Reconstruction) By End User (Hospitals and Specialty Clinics), and Regional Forecast, 2020-2027

The global breast implants market size was valued at USD 2.76 billion in 2019 and is projected to reach USD 3.05 billion by 2027, exhibiting a CAGR of 7.2% during the forecast period.

Cosmetic surgeries are witnessing a huge surge throughout the world. The demand for cosmetic surgery and aesthetic implants is increasing at a significant rate as a result of the importance given to physical appearance. Breast augmentation is the most common aesthetic surgery. Breast augmentation, also called breast enlargement, mammoplasty, or boob-job, is a surgical procedure that is carried out for increasing the size of the breast, using an implant or fat transfer. Many women prefer to undergo breast enlargement to enhance their physical appearance. According to the International Society of Aesthetic Plastic Surgery, the number of breast augmentation procedures in the world increased by 6.1% during 2017-2018.

In the era of social media and “selfie generation,” where people want to look desirable, many women opt for breast enhancement for an attractive physique. High emphasis on physical appearance, especially in the case of celebrities and the desire to look beautiful are the primary reasons responsible for the expansion of the market. Moreover, the market is poised to surge owing to the favorable health reimbursement for patients undergoing breast reconstruction post-mastectomy.

Decline in Supply of Medical Devices to Affect the Market during the Covid-19 Pandemic

The global healthcare industry has turned upside down during COVID-19 pandemic. The impact of the pandemic is overwhelming in the medical devices sector, with both ups and downs. On one hand, the demand for PPE kits and ventilators have increased drastically. On the other, the demand curve for medical devices such as implants, injectable, stents, equipment, and others is going downwards. Major factors for this scenario are disruptions in the supply chain and postponement or cancellation of elective surgeries.

The aesthetic industry is profoundly affected by the pandemic. The rising number of coronavirus cases has increased the burden on healthcare professionals. This has resulted in reallocations of resources such as ICUs, hospital beds, ventilators, and other medical instruments from all specialties and departments towards the treatment of COVID-19 patients. Hence, the governments across several countries have decided to postpone all the elective and non-essential procedures. As cosmetic surgeries such as breast enlargement, cheek augmentation, dermal injections, and others fall under the category of “non-essential” elective surgeries, they are all postponed or cancelled. For example, the NHS postponed 2 Mn planned surgeries to free up hospital beds. In March 2020, Centers for Medicare & Medicaid Services issued guidance to limit the elective surgeries in the U.S.

Besides this, cosmetic surgeons have decided to avoid breast enlargement surgeries owing to the risk of spreading coronavirus infection as the patient will have a weak immune system. This has dramatically declined the demand for both silicone and saline implants . According to CovidSurg, a platform developed by researcher to study the impact of COVID-19, over 28.4 Mn operations in the world are estimated to be cancelled or postponed during 12-week of COVID-19 infection. This is expected to negatively impact the market in 2020.

LATEST TRENDS

Request a Free sample to learn more about this report.

Gummy Bear Implants to Gain Significant Momentum

In recent years, gummy bear implants are gaining a lot of traction. The implant has a high degree of crosslinking that holds the shape of the implants and prevent wrinkles and is receiving wider acceptance from the women. It is an important advancement in silicone implants as they are deemed safer than conventional implants. The gummy bear implant is offering a more attractive alternative option for the women as they look more natural. Hence, they are considered apt for today’s “selfie-generation.” Apart from this, many plastic surgeons feel that they are more beneficial and suitable for use at the time of breast reconstruction after mastectomy. This has intensified the research on gummy bear implants and this is a primary reason why gummy bear implants are emerging as arapidly growing trend in the market. 

Furthermore, the emergence of under-the-muscle breast enlargement has revolutionized the market. Under-the-muscles breast augmentation is a minimally invasive procedure which is becoming popular among the women rather than the traditional procedure. Rapid adoption of minimally invasive breast augmentation is expected to provide significant momentum to the market.

DRIVING FACTORS

Increase in Number of Breast Augmentation Surgeries to Propel the Market Growth

The market is primarily driven by the rising number of breast surgeries across the world. Desire to look beautiful, especially among those belonging to elite groups and willingness to spend, has boosted the demand for breast implantation and enlargement. The highest number of breast implants procedures are performed in the United States, Brazil, and Mexico. According to the International Society of Aesthetic Plastic Surgery, more than 1.86 Mn breast augmentation were performed globally in 2018. This is likely to propel the growth of the market during 2020-2027. Furthermore, the desire among several women to have a celebrity look among women in many countries like Japan and China is anticipated to fuel market growth.  

Launch of Innovative Products to Drive the Market Growth

Launch of new products and technological advancements to provide visualization experience are also expected to augment the market growth. In June 2019, GC Aesthetics announced the launch of Eve 4.0, a Digital Consultation Solution (DCS) that provide visualization aids to the patients considering breast reconstruction or augmentation in Europe and Brazil. This is likely to propel the growth of the regional markets. Furthermore, increased research for the development of more durable implants is another factor driving the breast implants market growth. In February 2018, AMSilk GmbH collaborated with POLYTECH Health & Aesthetics to start a clinical study on SILKline, a silk-coated breast implant in Europe. The anticipated approval of the product is likely to create lucrative growth opportunities for the market.

RESTRAINING FACTORS

Risk of BIA-ALCL to Hamper the Market Growth

One of the prominent reasons hindering the market is the risk of Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Rare in nature, BIA-ALCL, is a type of T-cell lymphoma that usually develops around the tissue surrounding the implant. Many products are recalled from the market due to this factor. In September 2019, Allergan, now acquired by AbbVie, recalled Natrelle BIOCELL Textured Products from the market. According to the FDA, a total of 573 cases of BIA-ALCL was reported in 2019. Furthermore, the incidence of implant ruptures and safety concerns of women has made the government re-evaluate the manufacturer’s products. The aforementioned factors are expected to restrain the market growth.

SEGMENTATION

By Product Analysis

Rapid Adoption of Customizable Implants to Foster the Segment Growth

Based on product, the market is segmented into breast implants and tissue expanders. The breast implants segment accounted for the maximum portion of the market in 2019. Increasingnumber of breast augmentation surgeries and the launch of products with improved self-life are the major factors attributable to the growth of the segment. Moreover, the availability of implants in various shapes and sizes, as well as customizable sizes, is also anticipated to fuel the growth of the segment.

Tissue expander is a type of implant which is designed for stretching the muscles and tissues to make space for the implants. Increase in the number of breast reconstruction surgeries and rapid adoption of tissue expanders for breast reconstruction is contributing to the expansion of the segment during the forecast period.

By Material Analysis

To know how our report can help streamline your business, Speak to Analyst

Silicone Segment to Dominate the Market          

On the basis of material, the market is bifurcated into silicone and saline. The silicone segment generated the maximum revenue in 2019. The inclination towards  silicone implants, when compared to saline implants among cosmetic surgeons, is expected to favor the growth of the silicone segment. According to the International Society of Aesthetic Plastic Surgery, 91% of the plastic surgeons in the world perform breast enlargement with saline implants. This is anticipated to augment the segment growth.  

The saline segment is projected to expand owing to its cost-effectiveness. Saline implant is cheaper as compared to silicone implants. According to the International Society of Aesthetic Plastic Surgery, 70,683 breast augmentation surgeries were performed in the world using saline implants in 2017. This is estimated to drive the saline implants segment during the forecast period.

By Procedure Analysis

Rising Surgery Volume to Favor the Breast Augmentation Segment

In terms of procedure, the market for Breast Implants is segmented into breast augmentation and breast reconstruction. The breast augmentation segment accounted for the maximum breast implants market share in the global market. Increasing number of breast enlargement procedures, strategic collaboration between key players, and the growing influence of social media are the major factors that are anticipated to drive the segment. Furthermore, surge in medical tourism in countries such as Brazil and Mexico for aesthetic procedures where the services are less costly is also projected to propel the growth of the breast augmentation segment.

Although there is unclear health insurance for breast augmentation, reconstruction is reimbursed by many of the payers. Active government guidelines and favorable health reimbursement policies are major factors for the expansion of the breast reconstruction segment. Many women have to undergo mastectomy for treatment of breast cancer. The need for breast reconstruction after mastectomy is also another factor that is expected to fuel the growth of the segments covered.

By End User Analysis

Specialty Clinics to Register a Higher CAGR

In terms of end user, the market is categorized into hospitals and specialty clinics. The hospitals segment dominated the market in 2018 and will continue to dominate the market throughout the forecast period. Increase in the number of cosmetic surgeries in hospitals and the growing trend of medical tourism are the factors attributed to the growth of this segment.

On the other hand, the specialty clinics segment is projected to register remarkable growth during the forecast period. Rise in the number of standalone clinics and increasing number of cosmetic surgeons are anticipated to fuel thegrowth of the specialty clinics segment. According to the International Society of Aesthetic Plastic Surgery, in 2017, the estimated number of plastic surgeons in the world was 43,500, which is anticipated to foster the specialty clinics segment.

REGIONAL INSIGHTS

To get more information on the regional analysis of this market, Request a Free sample

The market size for Breast Implants in North America stood at USD 1.09 billion in 2019. High cost of the procedure as well as the implants, favorable health reimbursement for breast reconstruction, and the strategic position of the major manufacturers are the primary factors attributable to the expansion of the market in North America. According to the American Society for Aesthetic Plastic Surgery, 280,692 breast augmentation procedures were performed in the U.S. in 2018, which is expected to fuel the growth of the market in North America.

In Europe, the market is anticipated to derive growth from the high preference for silicone implants, increasing demand for cosmetic products, and active government initiatives to educate people about the various type of implants available for breast enlargement. In November 2018, POLYTECH Health & Aesthetics received CE approval for Polytech and B-Lite breast implants, for five years, as part of the company’s recertification, which will accelerate the market growth in Europe. 

Asia Pacific is projected to register significant growth in the market during the forecast period owing to the rapid adoption of cosmetic surgeries and increase in breast surgery in particularly in China and India. Latin America is estimated to serve as a lucrative segment owing to the high number of procedures performed in Brazil and the growing trend of medical tourism for cosmetic procedures. In the Middle East and Africa, the market is anticipated to grow owing to the increasing health spending and improving health infrastructure.

KEY INDUSTRY PLAYERS

AbbVie Inc. to Establish the Leading Position after Acquiring Allergan

In terms of market revenue for breast implants, AbbVie Inc. accounted for the maximum portion of the market. In March 2020, the company acquired Allergan, which also marked its entry into the aesthetic industry. The acquisition resulted in the inclusion of Allergan’s leading product portfolio and rendered the company a prominent position. Strong geographical footprints of the company and diversified product portfolio are expected to maintain the legacy of Allergan in the highly competitive market.

LIST OF KEY COMPANIES PROFILED:

• Sientra, Inc. (California, U.S.)


• GC Aesthetics (Dublin, Ireland)


• POLYTECH Health & Aesthetics GmbH (Dieburg, Germany)


• AbbVie Inc. (Illinois, U.S.)


• Mentor Worldwide LLC (California, U.S.)


• CEREPLAS (Cambrai, France)


• Establishment Labs S.A. (Alajuela, Costa Rica)


• LABORATOIRES ARION (Sophia Antipolis, France)


• Other Players

KEY INDUSTRY DEVELOPMENTS:

• March 2020: AbbVie Inc. announced the completion of acquisition of Allergan which rendered the company with the leading product portfolio of Allergan.


• June 2019 – GC Aesthetics announced the launch of Eve 4.0, a Digital Consultation Solution (DCS) that provide visualization aids to the patients considering breast reconstruction or augmentation surgery in Europe and Brazil.


• May 2019 - RealSelf partnered with The American Society for Aesthetic Plastic Surgery for conducting studies and development of resources to provide detailed information for implants available for breast enlargement and Brazilian butt lifts to consumers.


• November 2018 – POLYTECH Health & Aesthetics received CE approval for Polytech and B-Lite breast implants, for five years, as part of the company’s recertification


• February 2018 - AMSilk GmbH collaborated with POLYTECH Health & Aesthetics to start a clinical study on SILKline, a silk-coated breast implant in Europe.

REPORT COVERAGE

An Infographic Representation of Breast Implants Market

View Full Infographic

To get information on various segments, share your queries with us

The breast implants market research report provides detailed information regarding various insights of the market. Some of them are growth drivers, restraints, competitive landscape, regional analysis, and challenges. It further offers an analytical depiction of the market trends and estimations to illustrate the forthcoming investment pockets. The market is quantitatively analyzed from 2016 to 2027 to provide the financial competency of the market. Various key insights covered in the report are the number of breast augmentation surgery for key countries, number of breast reconstruction surgery for key countries, overview of material and shape of implants, regulatory scenarios for key countries, new product launch, and recent industry developments such as mergers & acquisitions.

Report Scope & Segmentation